| Literature DB >> 29574670 |
Iva Bozic1, Katarina Tesovic2, Danijela Laketa3, Marija Adzic3, Marija Jakovljevic2, Ivana Bjelobaba2, Danijela Savic2, Nadezda Nedeljkovic3, Sanja Pekovic2, Irena Lavrnja2.
Abstract
Kv1.3 is a voltage gated potassium channel that has been implicated in pathophysiology of multiple sclerosis (MS). In the present study we investigated temporal and cellular expression pattern of this channel in the lumbar part of spinal cords of animals with experimental autoimmune encephalomyelitis (EAE), animal model of MS. EAE was actively induced in female Dark Agouti rats. Expression of Kv1.3 was analyzed at different time points of disease progression, at the onset, peak and end of EAE. We here show that Kv1.3 increased by several folds at the peak of EAE at both gene and protein level. Double immunofluorescence analyses demonstrated localization of Kv1.3 on activated microglia, macrophages, and reactive astrocytes around inflammatory lesions. In vitro experiments showed that pharmacological block of Kv1.3 in activated astrocytes suppresses the expression of proinflammatory mediators, suggesting a role of this channel in inflammation. Our results support the hypothesis that Kv1.3 may be a therapeutic target of interest for MS and add astrocytes to the list of cells whose activation would be suppressed by inhibiting Kv1.3 in inflammatory conditions.Entities:
Keywords: Agitoxin-2; Astrocytes; Experimental autoimmune encephalomyelitis; Neuroinflammation; Voltage gated potassium channel Kv1.3
Mesh:
Substances:
Year: 2018 PMID: 29574670 DOI: 10.1007/s11064-018-2509-8
Source DB: PubMed Journal: Neurochem Res ISSN: 0364-3190 Impact factor: 3.996